{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:28:09Z","timestamp":1795015689803,"version":"4.10.1"},"reference-count":36,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","award":["TCMF-MP-110-03-01"],"award-info":[{"award-number":["TCMF-MP-110-03-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: Interstitial cystitis\/bladder pain syndrome (IC\/BPS) is a condition causing bladder inflammation. Urinary biomarkers have been assessed as suitable for the diagnosis and treatment. This study aimed at investigating the role of urinary biomarkers in identifying bladder conditions and predicting the treatment outcome of IC\/BPS. Methods: A total of 309 patients with IC\/BPS and 30 controls were enrolled in this study. All patients underwent a comprehensive urological workup of symptoms, pain severity, and cystoscopic hydrodistention findings including maximal bladder capacity (MBC) and glomerulation grade. Urine samples were collected to investigate the levels of urinary cytokines and chemokines. According to MBC and glomerulation grade, patients with IC\/BPS were further classified into the Hunner\u2019s IC (HIC) and non-HIC groups. The urinary biomarkers between IC\/BPS and control groups and HIC and non-HIC groups were compared. Moreover, the treatment response was graded according to global response assessment (GRA) scores, and urinary biomarker levels were analyzed based on different GRAs. Results: Patients with IC\/BPS had significantly high urinary monocyte chemoattractant protein-1, eotaxin, tumor necrosis factor -alpha (TNF-\u03b1), and prostaglandin E2 levels. Significantly higher levels of urinary interleukin-8, C-X-C motif chemokine ligand 10 (CXCL 10), brain-derived neurotrophic factor, eotaxin, and regulated-on-activation, normal T-cell expressed and secreted (RANTES) were noted in HIC than those with non-HIC and controls. Among all biomarkers, TNF-\u03b1 had the best sensitivity, specificity, positive predictive value, and negative predictive value. There was a significant correlation between biomarker levels and GRA. Conclusions: Significantly higher urine cytokines and chemokine levels were found in patients with IC\/BPS. Most urinary biomarkers were significantly associated with MBC, glomerulation grade, and treatment outcome.<\/jats:p>","DOI":"10.3390\/biomedicines10051149","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T08:34:29Z","timestamp":1652776469000},"page":"1149","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis\/Bladder Pain Syndrome"],"prefix":"10.3390","volume":"10","author":[{"given":"Wan-Ru","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Nursing, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan"},{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(01)01112-8","article-title":"Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases\/Interstitial Cystitis Association scientific conference on interstitial cystitis","volume":"57","author":"Hanno","year":"2001","journal-title":"Urology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Hanno","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_4","first-page":"25","article-title":"Pathology and terminology of interstitial cystitis\/bladder pain syndrome: A review","volume":"34","author":"Akiyama","year":"2019","journal-title":"Histol. Histopathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eururo.2009.08.020","article-title":"EAU guidelines on chronic pelvic pain","volume":"57","author":"Fall","year":"2010","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bju.14399","article-title":"Guideline of guidelines: Bladder pain syndrome","volume":"122","author":"Malde","year":"2018","journal-title":"BJU Int."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jhang, J.F., Hsu, Y.H., Ho, H.C., Jiang, Y.H., Lee, C.L., Yu, W.R., and Kuo, H.C. (2021). Possible association between bladder wall morphological changes on computed tomography and bladder-centered interstitial cystitis\/bladder pain syndrome. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101306"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: An ESSIC proposal","volume":"53","author":"Nordling","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/JU.0000000000001334","article-title":"Clinical relevance of bladder histopathological findings and their impact on treatment outcomes among patients with interstitial cystitis\/bladder pain syndrome: An investigation of the European Society for the Study of interstitial Cystitis histopathological classification","volume":"205","author":"Jhang","year":"2021","journal-title":"J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41598-020-80252-x","article-title":"Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment","volume":"11","author":"Yu","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Akiyama, Y. (2021). Biomarkers in interstitial cystitis\/bladder pain syndrome with and without Hunner Lesion: A review and future perspectives. Diagnostics, 11.","DOI":"10.3390\/diagnostics11122238"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/iju.12311","article-title":"Potential urine and serum biomarkers for patients with bladder pain syndrome\/interstitial cystitis","volume":"21","author":"Kuo","year":"2014","journal-title":"Int. J. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.urology.2021.05.005","article-title":"Diagnostic utility of serum and urinary metabolite analysis in patients with interstitial cystitis\/painful bladder syndrome","volume":"157","author":"Kim","year":"2021","journal-title":"Urology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41598-020-80131-5","article-title":"Urine biomarkers in ESSIC type 2 interstitial cystitis\/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm","volume":"11","author":"Jiang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"F1391","DOI":"10.1152\/ajprenal.00051.2020","article-title":"Urine cytokines as biomarkers for diagnosing interstitial cystitis\/bladder pain syndrome and mapping its clinical characteristics","volume":"318","author":"Jiang","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.urology.2005.07.014","article-title":"Responsiveness of symptom scales for interstitial cystitis","volume":"67","author":"Propert","year":"2006","journal-title":"Urology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/iju.12308","article-title":"Bladder afferent hyperexcitability in bladder pain syndrome\/interstitial cystitis","volume":"21","author":"Yoshimura","year":"2014","journal-title":"Int. J. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/iju.12379","article-title":"Gynecological disorders in bladder pain syndrome\/interstitial cystitis patients","volume":"21","author":"Cervigni","year":"2014","journal-title":"Int. J. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.ju.0000090192.36436.d5","article-title":"Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells","volume":"171","author":"Bouchelouche","year":"2004","journal-title":"J. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.juro.2012.01.034","article-title":"Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis","volume":"187","author":"Tyagi","year":"2012","journal-title":"J. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.juro.2011.09.142","article-title":"Gene expression analysis of urine sediment: Evaluation for potential noninvasive markers of interstitial cystitis\/bladder pain syndrome","volume":"187","author":"Blalock","year":"2012","journal-title":"J. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2249.2006.03113.x","article-title":"Monocyte chemoattractant protein-1 (MCP-1) inhibits the intestinal-like differentiation of monocytes","volume":"145","author":"Spoettl","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2249.2006.03085.x","article-title":"Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: Involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1\/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1\/2 signalling pathways","volume":"145","author":"Ip","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"F36","DOI":"10.1152\/ajprenal.00075.2017","article-title":"A MAPP Network study: Overexpression of tumor necrosis factor-alpha in mouse urothelium mimics interstitial cystitis","volume":"315","author":"Yang","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Lin, H.Y., Lu, J.H., Chuang, S.M., Chueh, K.S., Juan, T.J., Liu, Y.C., and Juan, Y.S. (2021). Urinary biomarkers in interstitial cystitis\/bladder pain syndrome and its impact on therapeutic outcome. Diagnostics, 12.","DOI":"10.3390\/diagnostics12010075"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1464-410X.2009.08851.x","article-title":"Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis\/bladder pain syndrome and detrusor overactivity","volume":"106","author":"Liu","year":"2010","journal-title":"BJU Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.juro.2014.07.108","article-title":"Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis\/bladder pain syndrome","volume":"193","author":"Nickel","year":"2015","journal-title":"J. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/RHU.0000000000000089","article-title":"Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: A review of case-control studies","volume":"20","author":"Mora","year":"2014","journal-title":"J. Clin. Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpsychores.2013.10.013","article-title":"Before the onset of interstitial cystitis\/bladder pain syndrome, the presence of multiple non-bladder syndromes is strongly associated with a history of multiple surgeries","volume":"76","author":"Warren","year":"2014","journal-title":"J. Psychosom. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.juro.2017.02.022","article-title":"Bladder capacity is a biomarker for a bladder centric versus systemic manifestation in interstitial cystitis\/bladder pain syndrome","volume":"198","author":"Walker","year":"2017","journal-title":"J. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/iju.13969","article-title":"Phenotyping of interstitial cystitis\/bladder pain syndrome","volume":"26","author":"Akiyama","year":"2019","journal-title":"Int. J. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0022-5347(05)66915-7","article-title":"Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis","volume":"164","author":"Denson","year":"2000","journal-title":"J. Urol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s00192-019-04038-0","article-title":"Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis\/bladder pain syndrome","volume":"30","author":"Schachar","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.urology.2007.10.069","article-title":"Proteomic investigation on chronic bladder irritation in the rat","volume":"71","author":"Tyagi","year":"2008","journal-title":"Urology"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., Peng, C.H., Liu, H.T., and Kuo, H.C. (2013). Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis\/bladder pain syndrome. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076779"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.urology.2012.06.059","article-title":"Temporal ordering of interstitial cystitis\/bladder pain syndrome and non-bladder conditions","volume":"80","author":"Clemens","year":"2012","journal-title":"Urology"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1149\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:11:38Z","timestamp":1760137898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["biomedicines10051149"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10051149","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]}}}